-
1
-
-
0027994133
-
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
-
Stöckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 1994;36:409-13
-
(1994)
Pediatr Res
, vol.36
, pp. 409-413
-
-
Stöckler, S.1
Holzbach, U.2
Hanefeld, F.3
-
2
-
-
0034764751
-
Arginine:glycine amidinotransferase deficiency: The third inborn error of creatine metabolism in man
-
Item CB, Stöckler-Ipsiroglu S, Stromberger C, et al. Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in man. Am J Hum Genet 2001;69:1127-33
-
(2001)
Am J Hum Genet
, vol.69
, pp. 1127-1133
-
-
Item, C.B.1
Stöckler-Ipsiroglu, S.2
Stromberger, C.3
-
3
-
-
12244277899
-
Creatine depletion in a new case with AGAT deficiency: Clinical and genetic study in a large pedigree
-
Battini R, Leuzzi V, Carducci CA, et al. Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. Mol Gen Metab 2002;77:326-31
-
(2002)
Mol Gen Metab
, vol.77
, pp. 326-331
-
-
Battini, R.1
Leuzzi, V.2
Carducci, C.A.3
-
4
-
-
0030596907
-
Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism
-
Stöckler S, Hanefeld F, Frahm J. Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 1996;348:789-90
-
(1996)
Lancet
, vol.348
, pp. 789-790
-
-
Stöckler, S.1
Hanefeld, F.2
Frahm, J.3
-
5
-
-
0031457381
-
Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: Diagnostic tools of a new inborn error of metabolism
-
Schulze A, Hess T, Wevers R, et al. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools of a new inborn error of metabolism. J Pediatr 1997;131:626-31
-
(1997)
J Pediatr
, vol.131
, pp. 626-631
-
-
Schulze, A.1
Hess, T.2
Wevers, R.3
-
6
-
-
0030722925
-
Guanidinoacetate methyltransferase deficiency: New clinical features
-
Ganesan V, Johnson A, Connelly A, et al. Guanidinoacetate methyltransferase deficiency: new clinical features. Pediatr Neurol 1997;17:155-57
-
(1997)
Pediatr Neurol
, vol.17
, pp. 155-157
-
-
Ganesan, V.1
Johnson, A.2
Connelly, A.3
-
7
-
-
33947576023
-
-
Von K Figura, F Hanefeld, D Ishrandt, et al. Guanidinoacetate methyltransferase deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Basis of Inherited disease, 6th ed. New York: McGraw Hill; 2000:1897-908
-
Von K Figura, F Hanefeld, D Ishrandt, et al. Guanidinoacetate methyltransferase deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Basis of Inherited disease, 6th ed. New York: McGraw Hill; 2000:1897-908
-
-
-
-
8
-
-
0034649446
-
Brain creatine depletion: A new case report of guanidinoacetate methyltransferase (improving with creatine supplementation)
-
Leuzzi V, Blanchi MC, Tosetti M, et al. Brain creatine depletion: a new case report of guanidinoacetate methyltransferase (improving with creatine supplementation). Neurology 2000;55:1407-09
-
(2000)
Neurology
, vol.55
, pp. 1407-1409
-
-
Leuzzi, V.1
Blanchi, M.C.2
Tosetti, M.3
-
9
-
-
0034032637
-
Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect
-
van der Knaap MS, Verhoeven NM, Maaswinkel-Mooij P, et al. Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect. Ann Neurol 2000;47:540-43
-
(2000)
Ann Neurol
, vol.47
, pp. 540-543
-
-
van der Knaap, M.S.1
Verhoeven, N.M.2
Maaswinkel-Mooij, P.3
-
10
-
-
0037309446
-
Lack of creatine in muscle and brain in an adult with GAMT deficiency
-
Schulze A, Bachert P, Schlemmer H, et al. Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol 2003;53:248-51
-
(2003)
Ann Neurol
, vol.53
, pp. 248-251
-
-
Schulze, A.1
Bachert, P.2
Schlemmer, H.3
-
11
-
-
0023376437
-
Biochemistry and neurotoxicology of guanidino compounds. History and recent advances
-
Mori A. Biochemistry and neurotoxicology of guanidino compounds. History and recent advances. Pavlov J Biol Sci 1987;22:85-94
-
(1987)
Pavlov J Biol Sci
, vol.22
, pp. 85-94
-
-
Mori, A.1
-
12
-
-
0026478010
-
Convulsive action and toxicity of uremic guanidine compounds: Behavioral assessment and relation to brain concentration in adult mice
-
D'Hooge R, Pei YQ, Marescau B, et al. Convulsive action and toxicity of uremic guanidine compounds: behavioral assessment and relation to brain concentration in adult mice. J Neurol Sci 1992;112:96-115
-
(1992)
J Neurol Sci
, vol.112
, pp. 96-115
-
-
D'Hooge, R.1
Pei, Y.Q.2
Marescau, B.3
-
14
-
-
0035098030
-
Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect?
-
Cecil KM, Salomons GS, Ball WS Jr., et al. Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect? Ann Neurol 2001;49:401-04
-
(2001)
Ann Neurol
, vol.49
, pp. 401-404
-
-
Cecil, K.M.1
Salomons, G.S.2
Ball Jr., W.S.3
-
15
-
-
0034987448
-
X-linked creatine-transporter gene (SLC6A8) defect: A new creatine-deficiency syndrome
-
Salomons GS, van Dooren SJ, Verhoeven NM, et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 2001;68:1497-500
-
(2001)
Am J Hum Genet
, vol.68
, pp. 1497-1500
-
-
Salomons, G.S.1
van Dooren, S.J.2
Verhoeven, N.M.3
-
17
-
-
25644446103
-
Laboratory diagnosis of defects of creatine biosynthesis and transport
-
Verhoeven NM, Salomons GS, Jakobs C. Laboratory diagnosis of defects of creatine biosynthesis and transport. Clin Chim Acta 2005;361:1-9
-
(2005)
Clin Chim Acta
, vol.361
, pp. 1-9
-
-
Verhoeven, N.M.1
Salomons, G.S.2
Jakobs, C.3
-
18
-
-
17044455914
-
Inborn errors of creatine metabolism and epilepsy: Clinical features, diagnosis and treatment
-
Leuzzi V. Inborn errors of creatine metabolism and epilepsy: clinical features, diagnosis and treatment. J Child Neurol 2002;17 (Suppl 3):S89-97
-
(2002)
J Child Neurol
, vol.17
, Issue.SUPPL. 3
-
-
Leuzzi, V.1
-
19
-
-
0037306564
-
Creatine deficiency syndromes
-
Schulze A. Creatine deficiency syndromes. Mol Cell Biochem 2003;244:143-50
-
(2003)
Mol Cell Biochem
, vol.244
, pp. 143-150
-
-
Schulze, A.1
-
20
-
-
0035694594
-
Improving treatment of guanidinoacetate methyltransferase deficiency: Reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation
-
Schulze A, Ebinger F, Rating D, et al. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 2001;74:413-19
-
(2001)
Mol Genet Metab
, vol.74
, pp. 413-419
-
-
Schulze, A.1
Ebinger, F.2
Rating, D.3
-
21
-
-
0034077740
-
Reversible brain creatine deficiency in two sisters with normal blood creatine level
-
Bianchi MC, Tosetti M, Fornai F, et al. Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann Neurol 2000;47:511-13
-
(2000)
Ann Neurol
, vol.47
, pp. 511-513
-
-
Bianchi, M.C.1
Tosetti, M.2
Fornai, F.3
-
22
-
-
0032054803
-
The gene encoding guanidinoacetate methyltransferase (GAMT) maps to human chromosome 19 at band p13.3 and to mouse chromosome 10
-
Chae YJ, Chung CK, Kim BJ, et al. The gene encoding guanidinoacetate methyltransferase (GAMT) maps to human chromosome 19 at band p13.3 and to mouse chromosome 10. Genomics 1998;49:162-64
-
(1998)
Genomics
, vol.49
, pp. 162-164
-
-
Chae, Y.J.1
Chung, C.K.2
Kim, B.J.3
-
23
-
-
0028911446
-
Assignment of the creatine transporter gene (SLC6A8) to human chromosome Xq28 telomeric to G6PD
-
Gregor P, Nash SR, Caron MG, et al. Assignment of the creatine transporter gene (SLC6A8) to human chromosome Xq28 telomeric to G6PD. Genomics 1995;25:332-33
-
(1995)
Genomics
, vol.25
, pp. 332-333
-
-
Gregor, P.1
Nash, S.R.2
Caron, M.G.3
-
24
-
-
0033935979
-
Creatine and creatinine metabolism
-
Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000;80:1107-213
-
(2000)
Physiol Rev
, vol.80
, pp. 1107-1213
-
-
Wyss, M.1
Kaddurah-Daouk, R.2
-
26
-
-
0027375098
-
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
-
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med l993;30:672-79
-
Magn Reson Med l993
, vol.30
, pp. 672-679
-
-
Provencher, S.W.1
-
27
-
-
33947581472
-
-
de Graaf RA. In Vivo NMR Spectroscopy: Principles and Technique. Chichester, UK: Wiley & Sons Ltd; 1998:61-67
-
de Graaf RA. In Vivo NMR Spectroscopy: Principles and Technique. Chichester, UK: Wiley & Sons Ltd; 1998:61-67
-
-
-
-
28
-
-
0034055660
-
On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain
-
Schirmer T, Auer DP. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 2000;13:28-36
-
(2000)
NMR Biomed
, vol.13
, pp. 28-36
-
-
Schirmer, T.1
Auer, D.P.2
-
29
-
-
0034526418
-
Two new severe mutations causing guanidinoacetate methyltransferase deficiency
-
Carducci Ca, Leuzzi V, Carducci CI, et al. Two new severe mutations causing guanidinoacetate methyltransferase deficiency. Mol Gen Metab 2000;71:633-38
-
(2000)
Mol Gen Metab
, vol.71
, pp. 633-638
-
-
Carducci, C.1
Leuzzi, V.2
Carducci, C.I.3
-
30
-
-
8044248588
-
Creatine deficiency in the brain: A new treatable inborn error of metabolism identified by proton and phosphorus MR spectroscopy in vivo
-
San Francisco, Calif, August 16-19
-
Frahm J, Requardt M, Helms G, et al. Creatine deficiency in the brain: a new treatable inborn error of metabolism identified by proton and phosphorus MR spectroscopy in vivo. In: Proceedings of the Second Annual Meeting of the Society of Magnetic Resonance, San Francisco, Calif, August 16-19, 1994
-
(1994)
Proceedings of the Second Annual Meeting of the Society of Magnetic Resonance
-
-
Frahm, J.1
Requardt, M.2
Helms, G.3
-
31
-
-
0242290992
-
MR spectroscopy of muscle and brain in guanidinoacetate methyltransferase (GAMT)-deficient mice: Validation of an animal model to study creatine deficiency
-
Renema WK, Schmidt A, van Asten JJ, et al. MR spectroscopy of muscle and brain in guanidinoacetate methyltransferase (GAMT)-deficient mice: validation of an animal model to study creatine deficiency. Magn Reson Med 2003;50:936-43
-
(2003)
Magn Reson Med
, vol.50
, pp. 936-943
-
-
Renema, W.K.1
Schmidt, A.2
van Asten, J.J.3
-
32
-
-
2442475483
-
Severey altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency
-
Schmidt A, Marescau B, Boehm EA, et al. Severey altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet 2004;13:905-21
-
(2004)
Hum Mol Genet
, vol.13
, pp. 905-921
-
-
Schmidt, A.1
Marescau, B.2
Boehm, E.A.3
-
33
-
-
0035977693
-
Endogenous synthesis and transport of creatine in the rat brain: An in situ hybridization study
-
Braissant O, Henry H, Loup M, et al. Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Mol Brain Res 2001;86:193-201
-
(2001)
Mol Brain Res
, vol.86
, pp. 193-201
-
-
Braissant, O.1
Henry, H.2
Loup, M.3
-
34
-
-
0026585611
-
Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The "phosphocreatine circuit" for cellular energy homeostasis
-
Wallimann T, Wyss M, Urdiczka D, et al. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis. Biochem J 1992;281:21-40
-
(1992)
Biochem J
, vol.281
, pp. 21-40
-
-
Wallimann, T.1
Wyss, M.2
Urdiczka, D.3
-
35
-
-
0028017704
-
Creatine kinase in non-muscle tissues and cells
-
Wallimann T, Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol and Cell Biochem 1994;133-134:193-220
-
(1994)
Mol and Cell Biochem
-
-
Wallimann, T.1
Hemmer, W.2
-
36
-
-
0036843535
-
The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain
-
Ohtsuki S, Tachikawa M, Takanaga H, et al. The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cereb Blood Flow Metab 2002;22:1327-35
-
(2002)
J Cereb Blood Flow Metab
, vol.22
, pp. 1327-1335
-
-
Ohtsuki, S.1
Tachikawa, M.2
Takanaga, H.3
-
37
-
-
0021105244
-
Anatomical considerations for interpreting topical 31P-NMR
-
Pettegrew J, Minshew NJ, Diehl J, et al. Anatomical considerations for interpreting topical 31P-NMR. Lancet 1983;2(8355):913
-
(1983)
Lancet
, vol.2
, Issue.8355
, pp. 913
-
-
Pettegrew, J.1
Minshew, N.J.2
Diehl, J.3
-
38
-
-
0021345885
-
Surface coil NMR spectroscopy of brain
-
Tofts PS, Cady EB, Delpy DT, et al. Surface coil NMR spectroscopy of brain. Lancet 1984;i:459
-
(1984)
Lancet
, Issue.I 459
-
-
Tofts, P.S.1
Cady, E.B.2
Delpy, D.T.3
-
39
-
-
0032565380
-
Renal dysfunction accompanying oral creatine supplements
-
Pritchard NR, Kalra PA. Renal dysfunction accompanying oral creatine supplements. Lancet 1998;351:1252-53
-
(1998)
Lancet
, vol.351
, pp. 1252-1253
-
-
Pritchard, N.R.1
Kalra, P.A.2
-
41
-
-
0035008935
-
Clinical pharmacology of the dietary supplement creatine monohydrate
-
Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 2001;53:161-76
-
(2001)
Pharmacol Rev
, vol.53
, pp. 161-176
-
-
Persky, A.M.1
Brazeau, G.A.2
|